Heilbron, Karl
Noyce, Alastair J.
Fontanillas, Pierre
Alipanahi, Babak https://orcid.org/0000-0001-8216-7178
Nalls, Mike A.
,
Agee, M.
Auton, A.
Bell, R. K.
Bryc, K.
Elson, S. L.
Furlotte, N. A.
Hinds, D. A.
McCreight, J. C.
Huber, K. E.
Kleinman, A.
Litterman, N. K.
McIntyre, M. H.
Mountain, J. L.
Noblin, E. S.
Northover, C. A. M.
Pitts, S. J.
Sathirapongsasuti, J. F.
Sazonova, O. V.
Shelton, J. F.
Shringarpure, S.
Tian, C.
Tung, J. Y.
Vacic, V.
Wilson, C. H.
Cannon, Paul
Funding for this research was provided by:
Michael J. Fox Foundation for Parkinson's Research (MJFF12737, MJFF12737, MJFF12737)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (Z01-AG000949-02)
Article History
Received: 29 October 2018
Accepted: 4 March 2019
First Online: 27 March 2019
Competing interests
: Drs. Heilbron, Fontanillas, Alipanahi, Cannon, and members of the 23andMe Research Team are employees of and have stock, stock options, or both, in 23andMe. Dr. Nalls is supported by a consulting contract between Data Tecnica International and the National Institute on Aging (project number: Z01-AG000949-02). The remaining authors declare no competing interests.